INDIANAPOLIS—For the fifth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, showcasing its continued leadership in the field of medical research.
Supported by a $1.3 million grant from the U.S. Administration for Community Living, Department of Health and Human Services, Indiana University School of Medicine and its partners have launched a 36-month venture to enhance, strengthen and expand supports for people with Alzheimer’s Disease and Related Dementias and their caregivers in 34 Indiana counties.
A veteran researcher and Indiana University School of Medicine faculty member will be taking on a new role with the Indiana Biosciences Research Institute—a leading industry-inspired applied research institute. Alan Palkowitz, PhD, was named the new president and CEO of the IBRI in an announcement on Wednesday, September 2. Palkowitz will spend 80 percent of his time at the IBRI serving in this new position, while maintaining his role at IU School of Medicine as a senior research professor of medicine and leader of the IUSM-Purdue TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) Center.
INDIANAPOLIS – For the fourth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, demonstrating national leadership in critical fields like Alzheimer’s disease and pediatrics and providing a major boost to the Indiana economy. IU School of Medicine scientists and physicians were awarded over […]
INDIANAPOLIS – Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia. The researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from screening for Alzheimer’s disease and related dementia in diverse […]
INDIANAPOLIS — Indiana University School of Medicine has been awarded a grant expected to total $36 million over five years from the National Institutes of Health to launch a drug discovery center to accelerate the development of promising treatments for Alzheimer’s disease. The center is a strategic partnership with the Purdue Institute for Drug Discovery. […]
Indianapolis, IN – August 19, 2019 – The Alzheimer’s Association Greater Indiana Chapter today announced it is funding a $1 million add-on study focusing on genetics to the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) led by Indiana University School of Medicine. The additional funding will allow researchers to study the entire genome of all 600 […]
New research from the Alzheimer’s Disease Metabolomics Consortium (ADMC) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) has uncovered novel connections between liver dysfunction and Alzheimer’s disease (AD), paving a new path toward a systems level view of Alzheimer’s relevant for early detection and ultimately for prevention. The study, published today in JAMA Network Open, was led […]
INDIANAPOLIS — An international team of scientists at Indiana University School of Medicine, University of Kansas and the U.K. Medical Research Council have dismantled the belief that Alzheimer’s disease and Chronic Traumatic Encephalopathy have identical pathology. Their discovery offers options for improved diagnosis and potential targeted treatments. CTE has been making headlines across the sports […]